Figure 3. Prevalence, burden of disease (in disability-adjusted life-years [DALYs]), attributable mortality and percentage of RCTs included in Cochrane systematic reviews and ongoing RCTs selected from international clinical trial registries for different regions of the world for trials of tobacco use (A) and HIV infection (B).